| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activated clotting time in inpatient diagnostic and interventional settings
|
Dalton, Heidi
|
|
|
54 |
4 |
p. 660-668
|
artikel
|
| 2 |
A survey of internists’ recommendations for aspirin in older adults and barriers to evidence-based use
|
Schaefer, Jordan K.
|
|
|
54 |
4 |
p. 639-646
|
artikel
|
| 3 |
Biomarkers associated with coronary high-risk plaques
|
Nakajima, Akihiro
|
|
|
54 |
4 |
p. 647-659
|
artikel
|
| 4 |
Correction: Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID‑19 in the United States: a retrospective cohort study
|
Deitelzweig, Steve
|
|
|
54 |
4 |
p. 696
|
artikel
|
| 5 |
Direct oral anticoagulants for the treatment of atrial fibrillation in patients with hematologic malignancies
|
Serrao, Alessandra
|
|
|
54 |
4 |
p. 625-629
|
artikel
|
| 6 |
Evaluation of the use of direct oral anticoagulants for the management of heparin-induced thrombocytopenia
|
Albuloushi, Asmaa
|
|
|
54 |
4 |
p. 597-604
|
artikel
|
| 7 |
Increased risk of venous thromboembolism among patients with familial Mediterranean fever
|
Gendelman, Omer
|
|
|
54 |
4 |
p. 669-674
|
artikel
|
| 8 |
In-hospital prognosis of malignancy-related pulmonary embolism: an analysis of the national inpatient sample 2016–2018
|
Park, Dae Yong
|
|
|
54 |
4 |
p. 630-638
|
artikel
|
| 9 |
Long-term outcomes in acute coronary syndrome patients without standard modifiable risk factors: a multi-ethnic retrospective cohort study Of 5400 asian patients
|
Kong, Gwyneth
|
|
|
54 |
4 |
p. 569-578
|
artikel
|
| 10 |
Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series
|
Vazquez, Sara R.
|
|
|
54 |
4 |
p. 583-586
|
artikel
|
| 11 |
Post-thrombolytic coagulopathy and complications in patients with pulmonary embolism treated with fixed-dose systemic alteplase
|
Lillyblad, Matthew P.
|
|
|
54 |
4 |
p. 605-615
|
artikel
|
| 12 |
Prescribing of anticoagulation for atrial fibrillation in primary care
|
Martinez, Kathryn A.
|
|
|
54 |
4 |
p. 616-624
|
artikel
|
| 13 |
SARS-CoV-2 antibody research in patients with unprovoked pulmonary embolism in COVID-19 pandemic period
|
Atahan, Ersan
|
|
|
54 |
4 |
p. 587-592
|
artikel
|
| 14 |
The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTORTM2 trial to a real-world study: a head-to-head comparison
|
Pasca, Samantha
|
|
|
54 |
4 |
p. 593-596
|
artikel
|
| 15 |
Thromboembolic complications of recreational nitrous oxide (ab)use: a systematic review
|
Oulkadi, Sanad
|
|
|
54 |
4 |
p. 686-695
|
artikel
|
| 16 |
Utilization of D-dimer assay, CT angiography, and the incidence of pulmonary embolism in the hospital district of Helsinki and Uusimaa (2011–2017)
|
Sane, Markus
|
|
|
54 |
4 |
p. 579-582
|
artikel
|
| 17 |
Utilization trends and outcomes of catheter-directed thrombolysis for pulmonary embolism in the US by race/ethnicity
|
Olanipekun, Titilope
|
|
|
54 |
4 |
p. 675-685
|
artikel
|
Tijdschrift beschrijving